280 related articles for article (PubMed ID: 33588783)
41. Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma.
Reizine E; Ronot M; Ghosn M; Calderaro J; Frulio N; Bioulac-Sage P; Trillaud H; Vilgrain V; Paradis V; Luciani A
Eur Radiol; 2021 May; 31(5):3417-3426. PubMed ID: 33146794
[TBL] [Abstract][Full Text] [Related]
42. [The application value of Gd-EOB-DTPA enhanced MRI based radiomics in the differential diagnosis of iso-or hyperintensity HCC and focal nodular hyperplasia in hepatobiliary phase].
Mao HY; Yu YX; Zhang JY; Zhang T; Fan YF; Hu S; Wang XM; Hu CH
Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(33):2599-2606. PubMed ID: 37650206
[No Abstract] [Full Text] [Related]
43. Evaluation of texture analysis for the differential diagnosis of focal nodular hyperplasia from hepatocellular adenoma on contrast-enhanced CT images.
Cannella R; Borhani AA; Minervini MI; Tsung A; Furlan A
Abdom Radiol (NY); 2019 Apr; 44(4):1323-1330. PubMed ID: 30267107
[TBL] [Abstract][Full Text] [Related]
44. Differentiation of focal nodular hyperplasia from hepatocellular adenomas with low-mechanical-index contrast-enhanced sonography (CEUS): effect of size on diagnostic confidence.
Roche V; Pigneur F; Tselikas L; Roux M; Baranes L; Djabbari M; Costentin C; Calderaro J; Laurent A; Rahmouni A; Luciani A
Eur Radiol; 2015 Jan; 25(1):186-95. PubMed ID: 25120205
[TBL] [Abstract][Full Text] [Related]
45. Characterization of the arterial enhancement pattern of focal liver lesions by multiple arterial phase magnetic resonance imaging: comparison between hepatocellular carcinoma and focal nodular hyperplasia.
Gatti M; Calandri M; Bergamasco L; Darvizeh F; Grazioli L; Inchingolo R; Ippolito D; Rousset S; Veltri A; Fonio P; Faletti R
Radiol Med; 2020 Apr; 125(4):348-355. PubMed ID: 31916102
[TBL] [Abstract][Full Text] [Related]
46. The use of 18F-fluoromethylcholine PET/CT in differentiating focal nodular hyperplasia from hepatocellular adenoma: a prospective study of diagnostic accuracy.
Bieze M; Bennink RJ; El-Massoudi Y; Phoa SS; Verheij J; Beuers U; van Gulik TM
Nucl Med Commun; 2013 Feb; 34(2):146-54. PubMed ID: 23154640
[TBL] [Abstract][Full Text] [Related]
47. Gadoxetic Acid-Enhanced Hepatobiliary-Phase Magnetic Resonance Imaging for Delineation of Focal Nodular Hyperplasia: Superiority of High-Flip-Angle Imaging.
Sheng R; Palm V; Mayer P; Mokry T; Berger AK; Weiss KH; Longerich T; Kauczor HU; Weber TF
J Comput Assist Tomogr; 2018; 42(5):667-674. PubMed ID: 30119067
[TBL] [Abstract][Full Text] [Related]
48. Characterization of fortuitously discovered focal liver lesions: additional information provided by shearwave elastography.
Ronot M; Di Renzo S; Gregoli B; Duran R; Castera L; Van Beers BE; Vilgrain V
Eur Radiol; 2015 Feb; 25(2):346-58. PubMed ID: 25231131
[TBL] [Abstract][Full Text] [Related]
49. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.
Kim YN; Song JS; Moon WS; Hwang HP; Kim YK
Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310
[TBL] [Abstract][Full Text] [Related]
50. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.
Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M
World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948
[TBL] [Abstract][Full Text] [Related]
51. Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors.
Tselikas L; Pigneur F; Roux M; Baranes L; Costentin C; Roche V; Calderaro J; Herin E; Laurent A; Zafrani E; Azoulay D; Mallat A; Rahmouni A; Luciani A
Abdom Radiol (NY); 2017 Mar; 42(3):825-832. PubMed ID: 27704147
[TBL] [Abstract][Full Text] [Related]
52. Ring-like enhancement of focal nodular hyperplasia with hepatobiliary-phase Gd-EOB-DTPA-enhanced magnetic resonance imaging: radiological-pathological correlation.
Fujiwara H; Sekine S; Onaya H; Shimada K; Mikata R; Arai Y
Jpn J Radiol; 2011 Dec; 29(10):739-43. PubMed ID: 22009428
[TBL] [Abstract][Full Text] [Related]
53. Focal nodular hyperplasia and hepatocellular adenoma: The value of shear wave elastography for differential diagnosis.
Brunel T; Guibal A; Boularan C; Ducerf C; Mabrut JY; Bancel B; Boussel L; Rode A
Eur J Radiol; 2015 Nov; 84(11):2059-64. PubMed ID: 26299323
[TBL] [Abstract][Full Text] [Related]
54. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound.
Dietrich CF; Schuessler G; Trojan J; Fellbaum C; Ignee A
Br J Radiol; 2005 Aug; 78(932):704-7. PubMed ID: 16046421
[TBL] [Abstract][Full Text] [Related]
55. A Model-Based Prediction of the Probability of Hepatocellular Adenoma and Focal Nodular Hyperplasia Based on Characteristics on Contrast-Enhanced Ultrasound.
Taimr P; Bröker MEE; Dwarkasing RS; Hansen BE; de Knegt RJ; De Man RA; IJzermans JNM
Ultrasound Med Biol; 2017 Oct; 43(10):2144-2150. PubMed ID: 28743375
[TBL] [Abstract][Full Text] [Related]
56. Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma.
Fan Y; Yu Y; Hu M; Wang X; Du M; Guo L; Hu C
Br J Radiol; 2021 Mar; 94(1119):20200950. PubMed ID: 33417489
[TBL] [Abstract][Full Text] [Related]
57. Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET/CT.
van den Esschert JW; Bieze M; Beuers UH; van Gulik TM; Bennink RJ
Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):436-40. PubMed ID: 20717825
[TBL] [Abstract][Full Text] [Related]
58. Imaging Features of Hepatocellular Carcinoma: Quantitative and Qualitative Comparison Between MRI-Enhanced With Gd-EOB-DTPA and Gd-DTPA.
Son J; Hwang SH; Park S; Han K; Chung YE; Choi JY; Kim MJ; Park MS
Invest Radiol; 2019 Aug; 54(8):494-499. PubMed ID: 31094878
[TBL] [Abstract][Full Text] [Related]
59. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
60. Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns.
Denis de Senneville B; Frulio N; Laumonier H; Salut C; Lafitte L; Trillaud H
Eur Radiol; 2020 May; 30(5):2995-3003. PubMed ID: 32002637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]